XML 47 R30.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT INFORMATION (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
SCHEDULE OF SEGMENT INFORMATION

The following table presents selected financial information with respect to the Company’s single operating segment for the years ended December 31, 2024 and 2023:

 

   2024   2023 
         
Net sales  $128,133   $139,332 
Cost of goods sold   111,411    116,228 
Gross profit   16,722    23,104 
Operating expenses:          
Selling   3,446    3,598 
General and administrative   11,709    12,354 
Research and development   1,191    1,199 
Restructuring charges   571      
Total operating expenses   16,917    17,151 
(Loss) income from operations   (195)   5,953 
Other expense:          
Interest expense   (744)   (487)
(Loss) income before income taxes   (939)   5,466 
Income tax expense (benefit)   356    (1,408)
Net (loss) income  $(1,295)  $6,874 
SCHEDULE OF LONG LIVED TANGIBLE ASSETS

The Company’s long-lived tangible assets, including the Company’s operating lease assets recognized on the consolidated balance sheets were located as follows:

 

 SCHEDULE OF LONG LIVED TANGIBLE ASSETS

   2024   2023 
United States  $10,429   $9,421 
Mexico   2,445    2,870 
China   1,497    1,139 
Total long-lived tangible assets  $14,371   $13,430 
SCHEDULE OF NET SALES BY EMS INDUSTRY MARKETS

 

   2024   2023 
Medical Device  $34,636   $38,758 
Medical Imaging   37,492    39,908 
Industrial   35,517    40,113 
Aerospace and Defense   20,488    20,553 
Total net sales  $128,133   $139,332